Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 DuPont Launches Liveo Pharma TPE Overmolded Assemblies  | Contract Pharma
Breaking News

DuPont Launches Liveo Pharma TPE Overmolded Assemblies 

Customizable assemblies designed to help reduce leakage risk, contamination, and assembly time for ultrapure fluid transfer.

DuPont

DuPont has launched its Liveo Pharma TPE Overmolded Assemblies (OMAs), engineered for ultrapure fluid transfer across upstream and downstream pharmaceutical and biopharmaceutical processes.

Designed as critical components of single‑use systems, the new assemblies help reduce contamination risk, minimize the potential for leakage, and reduce in-house assembly and setup time.

OMAs support the transfer of ultrapure liquids, air or steam while helping manufacturers reduce cleaning, validation and labor requirements associated with traditional single-use systems. The assemblies are engineered for low extractables, strong chemical resistance, and improved heat‑welding performance.

The new TPE assemblies are available in both standard and ultra-low-temperature options designed to meet critical application requirements.

“DuPont Liveo Pharma TPE OMAs are customizable, help reduce the risk of leakage and contamination of ultrapure fluids, and minimize in‑house assembly and setup time and costs,” said Diana Salvadori, DuPont™ Liveo™ Global Senior Product Marketing Manager. “These OMAs are well‑suited for applications such as gene therapies; leak‑free connections; and other high‑value, critical applications, including fill‑and‑finish operations.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters